Clearance Summary
QC3 WHOLE HUMAN SERUM, HDL-CHOLESTEROL CONTROL received FDA 510(k) clearance under submission number K872078, sponsored by Solomon Park Research Laboratories. The device was reviewed via the Traditional premarket notification pathway and assigned to the Immunology review panel. The statutory decision date of record is 1987-06-18.
- Submission: K872078
- Applicant / Sponsor: Solomon Park Research Laboratories
- Clearance pathway: Traditional
- Review panel: Immunology
- Device class: Class II
- Regulation citation: 21 CFR 866.5580
- Decision date: 1987-06-18
Classification & Regulation
This clearance is catalogued under FDA product code DER and 21 CFR 866.5580, within the Immunology review panel as a Class II device.